Abstract
Sexual differentiation of the brain is influenced by testosterone and its metabolites during the perinatal period, when many aspects of brain development, including the maturation of GABAergic transmission, occur. Whether and how testosterone signaling during the perinatal period affects GABAergic transmission is unclear. Here, we analyzed GABAergic circuit functional markers in male, female, testosterone-treated female, and testosterone-insensitive male rats after the first postnatal week and in young adults. In the hippocampus, mRNA levels of proteins associated with GABA signaling were not significantly affected at postnatal day (P) 7 or P40. Conversely, membrane protein levels of KCC2, which are critical for determining inhibition strength, were significantly higher in females compared to males and testosterone-treated females at P7. Further, female and testosterone-insensitive male rats at P7 showed higher levels of the neurotrophin BDNF, which is a powerful regulator of neuronal function, including GABAergic transmission. Finally, spontaneous GABAergic currents in hippocampal CA1 pyramidal cells were more frequent in females and testosterone-insensitive males at P40. Overall, these results show that perinatal testosterone levels modulate GABAergic circuit function, suggesting a critical role of perinatal sex hormones in regulating network excitability in the adult hippocampus.
Similar content being viewed by others
Introduction
Female animal models have been consistently excluded from most basic neuroscience studies for decades1,2,3,4 despite the well documented sex bias observed in many neurological and neuropsychiatric conditions, such as autism spectrum disorders (ASD), epilepsy, mood disorders, multiple sclerosis, Alzheimer’s and Parkinson’s disease5,6,7,8,9. Therefore, considering sex as a biological variable (SABV) in the design and analysis of basic and clinical research is extremely important when making treatment decisions for both men and women3,10,11.
Hormonally influenced sex differences are caused by either activational or organizational effects of hormones12,13,14,15,16. Briefly, circulating gonadal hormones can have acute and transitory effects throughout life (activational effects), whereas exposure to gonadal hormones during developmental phases might result in persistent sex differences (organizational effects)17. Many molecular and cellular processes are influenced by gonadal hormones in the developing brain, including gene expression, cell birth and death, neurite outgrowth, synaptogenesis, and synaptic activity18. Extensive clinical observations suggest that males have a two-to-four times higher risk of being affected by neurodevelopmental disorders than females19. It has been suggested that gonadal hormones lead to functional difference in neuronal circuit development, thus contributing to sex bias in neurodevelopmental disorders5,20.
The balance between excitatory and inhibitory circuits is fundamental for all aspects of brain function21. Gamma-Aminobutyric acid (GABA), the principal inhibitory neurotransmitter, plays an important role in maintaining the inhibitory tone that counterbalances neuronal excitation. The inhibitory action of GABA relies on the inflow of chloride ions (Cl−), which hyperpolarises neurons in the brain. However, in early development, GABA signaling induces outward Cl− currents, resulting in membrane depolarization. The postnatal shift in GABA function relies on the developmentally regulated expression of the Na+–K+–2Cl− cotransporter 1 (NKCC1) and the K+–Cl− cotransporter 2 (KCC2). Immature neurons accumulate Cl− due to a high level of NKCC1, a Cl− importer, resulting in Cl− efflux and membrane depolarization upon GABAARs opening. Conversely, mature neurons express higher levels of the Cl− exporter, KCC2, which results in lower intracellular Cl− concentration which drives Cl− influx through GABAARs and leads to hyperpolarization22,23. Interestingly, recent studies showed that the timing of KCC2 and NKCC1 expression, and consequently the onset of mature inhibitory GABAergic neurotransmission during brain development, is sex dependent and occurs earlier in females compared to males24,25,26,27. However, it is unknown whether the observed sex difference in chloride transporter expression is dependent on perinatal hormones.
In this study, we explored the role of perinatal testosterone on GABAergic inhibition, by analyzing the expression of different molecular determinants of GABAergic neurotransmission and recording spontaneous and miniature GABAergic currents in hippocampal CA1 pyramidal neurons in males, females, masculinized females, and testosterone-insensitive males. Exogenous testosterone administration during sensitive periods of brain development induces adult male sexual behavior and brain anatomical patterns in female rodents28,29. On the other hand, the testicular feminization mutation (Tfm) is a naturally occurring point mutation of the gene encoding the androgen receptor (AR) that renders the Tfm male rat insensitive to physiological levels of androgens30. This latter approach allowed us to explore the organizational sex differences under baseline conditions, which are often undetected.
Results
Profile of neonatal testosterone and estradiol at birth
In rats, testicular testosterone production peaks in the late gestational period (E18) and is high throughout the first few postnatal days18. Therefore, to characterize the levels of plasma testosterone and estradiol in male, female, testosterone-treated female, and testosterone-insensitive male rats, samples were taken from spontaneously delivered pups within 24 h after birth, i.e., P0. We found that plasma testosterone levels were elevated in male, testosterone-treated female, as well as in testosterone-insensitive male rat pups when compared to female rat pups at birth (Fig. 1A; One-way ANOVA with Tukey’s post hoc analysis, F × M: p = 0.028; F × A: p < 0.001; F × TFM: p < 0.001). Conversely, there were no differences in plasma estradiol levels across the groups (Fig. 1B; One-way ANOVA with Tukey’s post hoc analysis, F × M: p = 0.995; F × A: p = 0.080; F × TFM: p = 0.140).
Perinatal testosterone determined sexual developmental markers
Sexual developmental marker analysis revealed that testosterone affected the anogenital distance (AGD) length and secondary sexual characteristics from birth until puberty (Fig. 2). At P1, we found smaller AGDs in females and testosterone-insensitive males, and larger AGDs in males and testosterone-treated females (Fig. 2A,D; One-way ANOVA with Tukey’s post hoc analysis, F × M, F × A TFM × M, TFM × A: p < 0.0001). At P15, we found that areolas were either absent or normal (prominent). All females and testosterone-insensitive males displayed normal areolas. Conversely, areolas were not detected in any male or testosterone-treated female offspring (Fig. 2A). At P35, sexual maturity was assessed in female and testosterone-treated female rats by inspecting the vaginal opening (VO). Testosterone treatment during the perinatal period affected the VO. Dissection of testosterone-insensitive male offspring at P40 revealed testes, confirming their male genotype (Fig. 2B,C). Overall, these results showed that the presence of androgens at the time of birth, like it occurs in normal males or in females treated perinatally with exogenous testosterone, resulted in the development of male-like phenotypes, which include development of secondary sexual characteristics. These results are in accordance with previous data showing that, while the Tfm mutation does not render AR completely non-functional, the decrease in function by 85–90%30 is enough to generate an entirely feminine external phenotype31. Notably, gonadal steroid production is intact in the Tfm male, resulting in testosterone levels that are rather high yet within the normal range32 as show in Fig. 1A.
Perinatal testosterone signaling did not affect mRNA levels of major molecular determinants of GABAergic neurotransmission
Previous studies have shown fluctuations in expression levels of GABA signaling components between sexes33,34. Therefore, to characterize the GABA signaling components in our four experimental groups, we quantified by RT-qPCR the mRNA expression levels of GABA-A receptor subunits (α1, α5, β2, γ2), GABA transporter (GAT-1), GABA synthesis (GAD65 and GAD67) and Chloride co-transporters (NKCC1 and KCC2) in hippocampal samples collected from the four groups at P7, when GABAergic circuits are still developing, and P40, when GABAergic transmission is considered mature. We found no significant difference in mRNAs expression levels for any GABA signaling components in all sex groups at both ages (Fig. 3A,B; One-way ANOVA with Tukey’s post hoc analysis, p > 0.05, fold change > 2 or < 0.5 for all comparisons). Therefore, testosterone signaling at birth seemed to not have any effects on the transcription of major molecular determinants of GABAergic signaling.
Testosterone signaling delayed membrane localisation of KCC2 during the first postnatal week
The increase of KCC2 expression during the first two postnatal weeks underlies the onset of powerful inhibitory neurotransmission in the hippocampus21,22,23. To evaluate the impact of testosterone on KCC2 expression, we quantified the monomeric (140KDa) form of KCC2 at two developmental ages, P7 and P40, by western blot. We did not observe any significant differences in KCC2 expression levels in whole cell lysates between any of the groups for KCC2 monomer band (Fig. 4A, Supplementary Fig. S1B,C; One-way ANOVA with Tukey’s post hoc analysis, p = 0.926 at P7; One-way ANOVA with Tukey’s post hoc analysis, p = 0.355, at P40) in contrast to what previously reported24,25. While KCC2 protein can be found both in cytoplasmic and plasmalemmal compartments, KCC2-dependent Cl-extrusion in neurons is mostly reliant on KCC2 localization at the membrane. Therefore, to investigate whether KCC2 localization at the membrane was sex dependent, we quantified KCC2 monomer levels in the membrane fractions from hippocampi of P7 and P40 rats (Fig. 4D, Supplementary Fig. S1). At P7, we found that KCC2 monomer levels in the membrane fractions were significantly higher in female when compared to males and testosterone-treated female rats (Fig. 4E; One-way ANOVA with Tukey’s post hoc analysis, F × M: p < 0.001; F × A: p = 0.001). Furthermore, testosterone-insensitive male rats showed higher KCC2 monomer levels in the membrane fractions when compared to male and testosterone-treated female rats at the same age (Fig. 4E; One-way ANOVA with Tukey’s post hoc analysis, TFM × M: p < 0.001; TFM × A: p = 0.001). Conversely, at P40 we observed no significant difference in KCC2 monomer levels in the membrane fractions between groups (Fig. 4F; One-way ANOVA with Tukey’s post hoc analysis, p = 0.121). Overall, our results showed that, during the first postnatal week, higher testosterone signaling was associated with lower KCC2 membrane localization.
BDNF expression was higher in females and testosterone-insensitive males during the first postnatal week
Several studies have suggested that BDNF may play a role in the developmental increase of KCC2 expression35,36,37. Sex steroid hormones may induce BDNF transcription, enhance CREB activity and modulate it epigenetically38,39,40, which may account for the functional discrepancies in BDNF between different sexes. Since we found that KCC2 localization in the membrane of hippocampal neurons was hormone dependent, we asked whether BDNF expression levels in the hippocampus at P7 were hormone dependent as well. We found higher levels of BDNF in the hippocampus of females and testosterone-insensitive males compared to male rat pups (Fig. 5A, Supplementary Fig. S2B; One-way ANOVA with Tukey’s post hoc analysis, F × M: p = 0.009; TFM × M: p = 0.007). Thus, these data show that during the first postnatal week higher testosterone signaling was associated with lower BDNF expression levels.
Perinatal testosterone affects spontaneous GABAergic neurotransmission in the adult hippocampus
To determine whether perinatal testosterone had long term consequences on GABAergic neurotransmission, we recorded miniature and spontaneous inhibitory postsynaptic currents (IPSCs) from pyramidal cells in the CA1 region of the dorsal hippocampus in P40 rats. We did not find any significant difference in mIPSC frequency (Fig. 6A,B; One-way ANOVA with Tukey’s post hoc analysis, p = 0.895) or amplitude (Fig. 6A,C; One-way ANOVA with Tukey’s post hoc analysis, p = 0.849) in the four experimental groups, suggesting that GABAergic synapse numbers or strength were not significantly affected by testosterone signaling during the perinatal period. Conversely, at the network level, we observed that the mean frequency of sIPSCs was significantly smaller in pyramidal neurons from males compared to pyramidal neurons from females and testosterone-insensitive males (Fig. 6D,E; One-way ANOVA with Tukey’s post hoc analysis, F × M: p = 0.002; TFM × M: p = 0.021). We further observed a decreased frequency of sIPSC in testosterone-treated females compared to females and testosterone-insensitive males (Fig. 6D,E; One-way ANOVA with Tukey’s post hoc analysis, F × A: p = 0.004; TFM × A: p = 0.030). sIPSC amplitude was not significantly different between the four experimental groups (Fig. 6D,F; One-way ANOVA with Tukey’s post hoc analysis, p = 0.067). Overall, these results suggest that perinatal testosterone signaling lead to overall reduced spontaneous inhibitory transmission in young adult rodents.
Discussion
In the present report, we provide evidence that membrane KCC2 localisation is negatively regulated by perinatal testosterone signaling in the hippocampus during the first postnatal week. We also demonstrated that perinatal testosterone signaling leads to decreased spontaneous inhibitory transmission in adult hippocampus. These data urge caution in generalizing findings regarding the cellular and molecular mechanisms underlying GABAergic circuit development and function in the different sexes.
During early postnatal development, a shift from GABAA-mediated excitation to inhibition occurs in a wide array of brain structures, including the hippocampus41,42. The developmental GABA switch in the hippocampus has traditionally been studied only in male rats. In recent years, research using female rats has revealed precocious GABAA transmission compared to male rats. In female rats, the GABA switch in CA1 and CA3 pyramidal neurons occurs between P4 and P7. In male rats, the transition occurs between P7 and P1422,25,43,44,45,46,47,48,49, suggesting a longer window of GABAA-mediated excitation in males compared to females. The mechanisms underlying these sex differences are poorly understood. It has been suggested that the testosterone surge that occurs perinatally in males50 promotes the expression and the activity of NKCC1, while decreasing the synthesis and activity of KCC251, which would result in males experiencing the GABA shift later than females. This effect has been shown not only in hippocampus, but also in substantia nigra reticulata neurons in acute slices52, and embryonic hypothalamic neurons in culture53. Our data show that testosterone signaling does not seem to alter KCC2 mRNA or protein levels, whereas it significantly limits KCC2 localisation at the membrane in males and masculinized females. Membrane KCC2 levels correlate with the development of inhibitory neurotransmission54; on the other hand, cytoplasmic KCC2 does not seem to affect the reversal potential, EGABA55. Therefore, our results suggest that KCC2 transporter activity may play a larger role in influencing EGABA in the female than in the male hippocampus during the first postnatal week. Functional evaluation of EGABA in the different experimental groups would further support this hypothesis. Altogether, the changes we observed in KCC2 localisation show an organizational effect of gonadal steroids. These effects might be brain region specific, since for example the GABA shift in Purkinje cells in the cerebellum is delayed in females compared to males56.
One of the most powerful modulators of KCC2 activity is BDNF37,57,58. Here, we report that overall BDNF expression levels are significantly higher in females compared to males during the first postnatal week. Consistent with our data, quantification of BDNF concentrations showed higher levels of BDNF in the hippocampus, ventromedial hypothalamus, and cortex in female compared to male rats59,60,61,62. Lower BDNF levels may play a role in reduced KCC2 plasmalemmal localization in males because BDNF has been found to enhance KCC2 membrane confinement35,58,63. Further experiments are needed to determine whether different BDNF levels underlie the effects of perinatal testosterone signaling on KCC2 membrane localisation. Nevertheless, these data indicate that when investigating the effects of BDNF in vivo, the sex of the animal models employed is a crucial variable to consider.
Gonadal hormones have been shown to influence synaptic transmission via genetic processes as well as fast changes in cell-to-cell communication64,65,66,67,68. In gonadotropin-releasing hormone neurons, estrogens control GABA release and cause bursts in GABAAR-dependent inhibitory postsynaptic currents69. Through its impact on GABAAR, another ovarian hormone, progesterone, and its metabolite allopregnanolone, also regulate inhibitory neurotransmission70,71. Here, we report that CA1 pyramidal neurons from females and testosterone-insensitive males show higher sIPSC frequency at the end of adolescence, which indicates an increase of spontaneous basal inhibition. This could be due to increased GABAergic circuit excitability or/and increased drive of GABAergic circuits synapsing onto CA1 pyramidal cells. All together, these data suggest that organizational perinatal testosterone leads to long lasting effects on spontaneous GABAergic activity in post-adolescent brain. Higher sIPSC frequency may lead to an overall decrease, or enhanced stability, of neuronal excitability, which could in turn contribute to a more resilient state of female compared to male brains against pathological states, such as epilepsy72,73. Further studies will be critical to understand how gonadal hormones impact different aspects of neuronal development, thus contributing to sex bias in specific developmental and pathological conditions.
Methods
Experimental models and prenatal procedures
Sprague–Dawley wild-type (wt) rats and Sprague–Dawley rats carrying the Tfm allele were bred with commercially purchased Sprague–Dawley (Charles River, St. Constant, QC, Canada) and were group housed in our colony at Sainte-Justine Hospital Research Centre within a 12-h light/dark cycle with free ad libitum access to food and water. Animal care, use and procedures were conducted in accordance with the Canadian Council on Animal Care regulations and conformed to the guidelines of protocols #617 and #696, which were approved by Comité Institutionnel de Bonnes Pratiques Animales en Recherche (CIBPAR) at Sainte-Justine Hospital Research Centre and Université de Montréal (Montreal, Quebec, Canada). This study also complies with the ARRIVE guidelines.
The testicular feminization mutation (Tfm) carriers were provided by Dr. Cindy Jordan (Michigan State University, MI, USA). Tfm is a naturally occurring point mutation of the gene that codes for the androgen receptor (AR), rendering the Tfm male rat insensitive to physiological levels of androgens30. Genotype was determined by extracting DNA from ear punches followed by PCR to detect Tfm versus wild type (WT) alleles for androgen receptor (AR), and the presence or absence of the Sry gene, which is located on the Y chromosome74 (Fig. 2B). For this study, we used WT males, WT females that were not carrying the Tfm allele, and Tfm males. The primer sequences for genotyping are listed in Table 1.
Pregnant dam body weight was measured from gestational day (GD) 1 (day of plug) to 14 to explore the rate of daily body weight gain during pregnancy. At GD14, dams were randomly assigned to one of the following treatments:
-
Vehicle: dams were injected s.c. with vehicle solution (sesame oil: 0.1 ml/rat) from GD14 to 19.
-
Testosterone: dams were injected s.c. with a 1 mg/0.1 ml of testosterone propionate solution (Testosterone propionate, MP Biomedicals, cat: 218655, lot: 40272, dissolved in Sesame oil) from GD14 to 19. Testosterone regimen was based on Wolf et al.31. All injections were performed at 1 PM during the light phase of the light/dark cycle. On the day of parturition, anogenital distance (AGD) was recorded. Rats were weaned at P21. Male and female offspring were housed in separate cages, with no more than five pups per cage, with standard rat chow and water ad libitum.
Sexual developmental markers
Sexual developmental markers were measured as described in Pallarés et al.75. AGD was measured using a vernier-caliper at P1. On P15, pups were re-examined for sexual phenotype, their sex confirmed or reassigned if necessary, and males and females were checked for areolas in a blind fashion. Areolas were deemed as either faint or normal, i.e. prominent and easily identified. On P35, female offspring were checked for vaginal opening (VO) and male offspring were monitored for testicular descent as indicators of puberty. Tfm males were dissected at P40 to confirm the presence of testis internally.
Hormone assays
Trunk blood was collected at birth, centrifuged to separate the plasma, and analyzed for testosterone and estradiol levels. Testosterone and estradiol concentrations were measured using AlphaLISA kit (Perkin Elmer, cat: AL324, lot: 2477098) and ELISA kit (Abcam, cat: ab108667, lot: GR3214106-3), respectively, following the company’s protocol.
RT-qPCR
Total RNA was extracted using the “Aurum Total RNA fatty and fibrous tissue” kit and following the steps outlined in “Section 8: Spin protocol” of the instruction manual (732-6830, Bio-rad). The quality of extracted total RNA was assessed using a Bioanalyzer (CHUSJ, Montreal, QC, Canada) and conformed with high purity and integrity standards to perform RT-qPCR. The reverse transcription of RNA into cDNA and the following qPCR were performed in collaboration with IRIC (Institute for Research in Immunology and Cancer, Montreal, QC, Canada). Three endogenous controls (ACTB, HPRT, GAPDH) were tested and GAPDH being the more stably expressed across samples was chosen for the final analysis as the reference gene. Details of RT-qPCR primer sequences are listed in Table 1.
Western blot
Whole lysate proteins and membrane protein fractions were extracted from hippocampal tissue at P7 and P40 following previously described protocols58,76. In particular, to obtain membrane protein fractions, samples were homogenized in 5 vol of HB (300 mM sucrose/10 mM Tris–HCl, pH 7.5/1 mM EDTA/protease inhibitor mixture) and centrifuged at 1000×g for 10 min at 4 °C. The pellet was washed in 0.5 vol HB and used as the nuclear fraction. Supernatants were centrifuged at 17,000×g for 15 min at 4 °C, yielding the mitochondria fraction. The supernatant was further separated by ultracentrifugation at 100,000×g for 1 h. The pellet and supernatant were used as the membrane and cytosol fractions, respectively. Membranes were probed with the following primary antibodies: anti-KCC2 1:1000 (rabbit polyclonal IgG; Cat. no. 07-432, Millipore), 1:200 anti-BDNF (BDNF, mouse monoclonal IgG, Cat. no. 327100, Icosagen), anti-glyceraldehyde-3-phosphate dehydrogenase 1:4000 (GAPDH, mouse monoclonal IgG; Cat. no. AM4300; Applied Biosystems) and anti-β dystroglycan 1:3000 (rabbit polyclonal IgG, Cat no. ab43125, Abcam). All samples were run simultaneously. Bands were quantified using ImageJ v.1.52 software (National Institutes of Health, USA, http://imagej.nih.gov/ij). The intensity of KCC2 and BDNF bands were normalized over the intensity of the GAPDH band for whole lysates or of the β dystroglycan band for membrane fractions, in the same lane (internal loading control). We did not quantify KCC2 dimer band because it was not detectable in all samples. Full gels of western blot with molecular weight markers are shown in Supplementary Figs. S1 and S2. During all experimental steps, the experimenter was blinded to the treatment groups.
Hippocampal slice preparation and in vitro electrophysiology
Brain slices were prepared as previously described by Sanon et al.77. Briefly, WT rats aged 38–42 days old were anaesthetized with isoflurane (Baxter corp, Mississauga, ON, Canada) and rapidly decapitated. The brain was extracted and immersed in cold (4 °C) and oxygenated (95% O2, 5% CO2) high sucrose cutting artificial cerebro-spinal fluid (ACSF) containing (in mM): 250 sucrose, 2 KCl, 0.5 CaCl2, 26 NaHCO3, 1.25 NaH2PO4, 7 MgSO4·7H2O, 10 D-glucose. Transverse cortical slices (300 µm) were cut using a vibratome (VT1000S, Leica Microsystems Inc., Buffalo, NY, USA) and placed in oxygenated ACSF containing (in mM): 126 NaCl, 3 KCl, 2 CaCl2, 25 NaHCO3, 1 NaH2PO4, 2 MgSO4·7H2O, 10 D-glucose (pH 7.3–7.4; 300–310 mOsm) at room temperature. Slices with coordinates − 3.08 to − 4.36 mm posterior to bregma from both hemispheres were allowed to recover a minimum of one hour before individual slices were transferred in a submerged recording chamber with ACSF flowing at a rate of 2 mL/min.
Whole-cell recordings were made using 1 mm (outer diameter) borosilicate patch pipettes (A-M Systems, Carlsborg, WA, USA) yielding a series resistance of 4–7 MΩ when filled with an intracellular solution containing (in mM) 140 CsCl, 5 NaCl, 2 MgCl2, 10 HEPES, 0.5 EGTA, 10 phosphocreatine, 2 ATP-tris, 0.4 GTP-Li (pH 7.2–7.3 adjusted with CsOH, 290 mOsm). Signals were acquired using an Axopatch 200B amplifier (low-pass filtering at 1 kHz). Data acquisition, at a sampling rate of 5 kHz was performed using a Digidata 1440A analog–digital converter (Molecular Devices, Sunnyvale, CA, USA) and pClamp10 software (Molecular Devices, Sunnyvale, CA, USA). We recorded from visually identified CA1 pyramidal cells of the hippocampus using an upright microscope (BX50WI, Olympus Canada, Markham, ON, Canada) equipped with differential interference contrast and infrared (DIC-IR) CCD video camera (KP M1U, Hitachi Denshi Ltd, Japan). To investigate the inhibitory activity onto hippocampal pyramidal cells, we recorded spontaneous inhibitory postsynaptic currents (sIPSC) in voltage-clamp mode at a membrane potential of − 60 mV and in presence of 6,7-dinitroquinoxaline-2,3-dione (DNQX, 40 μM), 2-amino-5-phosphonopentanoic acid (D-AP5, 50 μM), and routinely blocked these currents with bicuculline (BIC, 2 μM). Miniature inhibitory post-synaptic currents (mIPSCs) were measured in the presence of 0.5 μM TTX. Intrinsic properties, such as resting membrane potential, input resistance and capacitance were also analyzed. During all electrophysiological recordings, the experimenter was blinded to the treatment groups.
Statistical analysis
Statistical analysis and generation of figures was performed with RStudio (RStudio Inc., version 1.2.1335). Data was log-transformed to fit a normal distribution and assessed via one-way ANOVA for multiple comparisons between groups. Post-hoc Tukey’s test was performed to identify statistically significant differences when significant main effects were detected. The accepted threshold of significance for all statistical tests was set at a two-tailed p-value < 0.05. In particular, significance was considered as p-value < 0.05 and fold change > 2 or < 0.5 for all comparisons of qPCR data. All data are presented as mean ± standard error of the mean (SEM).
References
Will, T. R. et al. Problems and progress regarding sex bias and omission in neuroscience research. eNeuro 4, ENEURO. 0278-17.2017 (2017).
Cahill, L. Why sex matters for neuroscience. Nat. Rev. Neurosci. 7, 477–484 (2006).
Shansky, R. M. & Murphy, A. Z. Considering sex as a biological variable will require a global shift in science culture. Nat. Neurosci. 24, 457–464 (2021).
Beery, A. K. & Zucker, I. Sex bias in neuroscience and biomedical research. Neurosci. Biobehav. Rev. 35, 565–572 (2011).
Pinares-Garcia, P., Stratikopoulos, M., Zagato, A., Loke, H. & Lee, J. Sex: A significant risk factor for neurodevelopmental and neurodegenerative disorders. Brain Sci. 8, 154 (2018).
Loke, H., Harley, V. & Lee, J. Biological factors underlying sex differences in neurological disorders. Int. J. Biochem. Cell Biol. 65, 139–150 (2015).
Gilli, F., DiSano, K. D. & Pachner, A. R. SeXX matters in multiple sclerosis. Front. Neurol. 11, 616 (2020).
Baron-Cohen, S. et al. Why are Autism Spectrum conditions more prevalent in Males?. PLoS Biol. 9, e1001081 (2011).
Carlson, C., Dugan, P., Kirsch, H. E. & Friedman, D. Sex differences in seizure types and symptoms. Epilepsy Behav. 41, 103–108 (2014).
Shansky, R. M. & Woolley, C. S. Considering sex as a biological variable will be valuable for neuroscience research. J. Neurosci. 36, 11817–11822 (2016).
Clayton, J. Studying both sexes: A guiding principle for biomedicine. FASEB J. 30, 519–524 (2016).
Arnold, A. P. & Breedlove, S. M. Organizational and activational effects of sex steroids on brain and behavior: A reanalysis. Horm. Behav. 19, 469–498 (1985).
Cooke, B., Hegstrom, C. D., Villeneuve, L. S. & Breedlove, S. M. Sexual differentiation of the vertebrate brain: Principles and mechanisms. Front. Neuroendocrinol. 19, 323–362 (1998).
Hiemke, C., Banger, M., Kohsik, R., Hundt, M. & Ghraf, R. Actions of sex hormones on the brain. Prog. Neuropsychopharmacol. Biol. Psychiatry 16, 377–388 (1992).
McEwen, B. S. Steroid hormones and the brain: Cellular mechanisms underlying neural and behavioral plasticity. Psychoneuroendocrinology 5, 1–11 (1980).
Arnold, A. P. The organizational-activational hypothesis as the foundation for a unified theory of sexual differentiation of all mammalian tissues. Horm. Behav. 55, 570–578 (2009).
McCarthy, M. M. & Arnold, A. P. Reframing sexual differentiation of the brain. Nat. Neurosci. 14, 677–683 (2011).
Kight, K. E. & McCarthy, M. M. Using sex differences in the developing brain to identify nodes of influence for seizure susceptibility and epileptogenesis. Neurobiol. Dis. 72, 136–143 (2014).
May, T., Adesina, I., McGillivray, J. & Rinehart, N. J. Sex differences in neurodevelopmental disorders. Curr. Opin. Neurol. 32, 622–626 (2019).
Hanamsagar, R. & Bilbo, S. D. Sex differences in neurodevelopmental and neurodegenerative disorders: Focus on microglial function and neuroinflammation during development. J. Steroid Biochem. Mol. Biol. 160, 127–133 (2016).
Peerboom, C. & Wierenga, C. J. The postnatal GABA shift: A developmental perspective. Neurosci. Biobehav. Rev. 124, 179–192 (2021).
Rivera, C. et al. The K+/Cl− co-transporter KCC2 renders GABA hyperpolarizing during neuronal maturation. Nature 397, 251–255 (1999).
Di Cristo, G., Awad, P. N., Hamidi, S. & Avoli, M. KCC2, epileptiform synchronization, and epileptic disorders. Prog. Neurobiol. 162, 1–16 (2018).
Galanopoulou, A. S. Sexually dimorphic expression of KCC2 and GABA function. Epilepsy Res. 80, 99–113 (2008).
Murguía-Castillo, J., Beas-Zárate, C., Rivera-Cervantes, M. C., Feria-Velasco, A. I. & Ureña-Guerrero, M. E. NKCC1 and KCC2 protein expression is sexually dimorphic in the hippocampus and entorhinal cortex of neonatal rats. Neurosci. Lett. 552, 52–57 (2013).
McCarthy, M. M., Auger, A. P. & Perrot-Sinal, T. S. Getting excited about GABA and sex differences in the brain. Trends Neurosci. 25, 307–312 (2002).
Galanopoulou, A. S. & Moshé, S. L. Role of sex hormones in the sexually dimorphic expression of KCC2 in rat substantia nigra. Exp. Neurol. 184, 1003–1009 (2003).
Mong, J. A., Glaser, E. & McCarthy, M. M. Gonadal steroids promote glial differentiation and alter neuronal morphology in the developing hypothalamus in a regionally specific manner. J. Neurosci. 19, 1464–1472 (1999).
Guillamón, A., Segovia, S. & del Abril, A. Early effects of gonadal steroids on the neuron number in the medial posterior region and the lateral division of the bed nucleus of the stria terminalis in the rat. Dev. Brain Res. 44, 281–290 (1988).
Yarbrough, W. G. et al. A single base mutation in the androgen receptor gene causes androgen insensitivity in the testicular feminized rat. J. Biol. Chem. 265, 8893–8900 (1990).
Wolf, C. J., Hotchkiss, A., Ostby, J. S., LeBlanc, G. A. & Gray, L. E. Effects of prenatal testosterone propionate on the sexual development of male and female rats: A dose-response study. Toxicol. Sci. 65, 71–86 (2002).
Roselli, C. E., Salisbury, R. L. & Resko, J. A. Genetic evidence for androgen-dependent and independent control of aromatase activity in the rat brain. Endocrinology 121, 2205–2210 (1987).
Pandya, M. et al. Sex- and age-related changes in GABA signaling components in the human cortex. Biol. Sex Differ. 10, 1–16 (2019).
Barth, C., Villringer, A. & Sacher, J. Sex hormones affect neurotransmitters and shape the adult female brain during hormonal transition periods. Front. Neurosci. 9, 37 (2015).
Ludwig, A. et al. Early growth response 4 mediates BDNF induction of potassium chloride cotransporter 2 transcription. J. Neurosci. 31, 644–649 (2011).
Fernando, A. et al. BDNF regulates spontaneous correlated activity at early developmental stages by increasing synaptogenesis and expression of the K+/Cl− co-transporter KCC2. Development 130, 1267–1280 (2003).
Kaila, K., Price, T. J., Payne, J. A., Puskarjov, M. & Voipio, J. Cation-chloride cotransporters in neuronal development, plasticity and disease. Nat. Rev. Neurosci. 15, 637–654 (2014).
Moreno-Piovano, G. S., Varayoud, J., Luque, E. H. & Ramos, J. G. Long-term ovariectomy increases BDNF gene methylation status in mouse hippocampus. J. Steroid Biochem. Mol. Biol. 144, 243–252 (2014).
Sohrabji, F., Miranda, R. C. & Toran-Allerand, C. D. Identification of a putative estrogen response element in the gene encoding brain-derived neurotrophic factor. Proc. Natl. Acad. Sci. 92, 11110–11114 (1995).
Toran-Allerand, C. D. et al. Estrogen receptors colocalize with low-affinity nerve growth factor receptors in cholinergic neurons of the basal forebrain. Proc. Natl. Acad. Sci. U. S. A. 89, 4668–4672 (1992).
Ben-Ari, Y., Gaiarsa, J. L., Tyzio, R. & Khazipov, R. GABA: A pioneer transmitter that excites immature neurons and generates primitive oscillations. Physiol. Rev. 87, 1215–1284 (2007).
Ben-Ari, Y. et al. Refuting the challenges of the developmental shift of polarity of GABA actions: GABA more exciting than ever!. Front. Cell. Neurosci. 6, 35 (2012).
Ts, P.-S., Ap, A. & Mm, M. Excitatory actions of GABA in developing brain are mediated by l-type Ca2+ channels and dependent on age, sex, and brain region. Neuroscience 116, 995–1003 (2003).
Galanopoulou, A. S. Dissociated gender-specific effects of recurrent seizures on GABA signaling in CA1 pyramidal neurons: role of GABA(A) receptors. J. Neurosci. 28, 1557–1567 (2008).
Tyzio, R., Holmes, G. L., Ben-Ari, Y. & Khazipov, R. Timing of the developmental switch in GABAA mediated signaling from excitation to inhibition in CA3 rat hippocampus using gramicidin perforated patch and extracellular recordings. Epilepsia 48, 96–105 (2007).
Damborsky, J. C. & Winzer-Serhan, U. H. Effects of sex and chronic neonatal nicotine treatment on Na2+/K+/Cl− co-transporter 1, K+/Cl− co-transporter 2, brain-derived neurotrophic factor, NMDA receptor subunit 2A and NMDA receptor subunit 2B mRNA expression in the postnatal rat hippocampus. Neuroscience 225, 105–117 (2012).
Nuñez, J. L. & McCarthy, M. M. Evidence for an extended duration of GABA-mediated excitation in the developing male versus female hippocampus. Dev. Neurobiol. 67, 1879–1890 (2007).
Jl, N. & Mm, M. Estradiol exacerbates hippocampal damage in a model of preterm infant brain injury. Endocrinology 144, 2350–2359 (2003).
Nuñez, J. L. & McCarthy, M. M. Resting intracellular calcium concentration, depolarizing Gamma-Aminobutyric Acid and possible role of local estradiol synthesis in the developing male and female hippocampus. Neuroscience 158, 623–634 (2009).
Dean, S. L. & McCarthy, M. M. Steroids, sex and the cerebellar cortex: Implications for human disease. Cerebellum 7, 38–47 (2008).
Waddell, J. & McCarthy, M. M. Sexual differentiation of the brain and ADHD: What is a sex difference in prevalence telling us?. Curr. Top. Behav. Neurosci. 9, 341 (2012).
Kyrozis, A., Chudomel, O., Moshé, S. L. & Galanopoulou, A. S. Sex-dependent maturation of GABAA receptor-mediated synaptic events in rat substantia Nigra reticulata. Neurosci. Lett. 398, 1–5 (2006).
Mir, F. R., Carrer, H. F. & Cambiasso, M. J. Sex differences in depolarizing actions of GABAA receptor activation in rat embryonic hypothalamic neurons. Eur. J. Neurosci. 45, 521–527 (2017).
Mahadevan, V. et al. Neto2-null mice have impaired GABAergic inhibition and are susceptible to seizures. Front. Cell. Neurosci. 9, 368–368 (2015).
Khalilov, I. et al. Enhanced synaptic activity and epileptiform events in the embryonic KCC2 deficient hippocampus. Front. Cell. Neurosci. 5, 23 (2011).
Roux, S., Lohof, A., Ben-Ari, Y., Poulain, B. & Bossu, J.-L. Maturation of GABAergic transmission in cerebellar purkinje cells is sex dependent and altered in the valproate model of autism. Front. Cell. Neurosci. 0, 232 (2018).
Rivera, C. et al. BDNF-induced TrkB activation down-regulates the K+-Cl− cotransporter KCC2 and impairs neuronal Cl− extrusion. J. Cell Biol. 159, 747–752 (2002).
Awad, P. N. et al. KCC2 regulates dendritic spine formation in a brain-region specific and BDNF dependent manner. Cereb. Cortex 28, 4049–4062 (2018).
Bakos, J. et al. Enriched environment influences hormonal status and hippocampal brain derived neurotrophic factor in a sex dependent manner. Neuroscience 164, 788–797 (2009).
Bland, S. T. et al. Expression of c-fos and BDNF mRNA in subregions of the prefrontal cortex of male and female rats after acute uncontrollable stress. Brain Res. 1051, 90–99 (2005).
Liu, X., Zhu, Z., Kalyani, M., Janik, J. M. & Shi, H. Effects of energy status and diet on Bdnf expression in the ventromedial hypothalamus of male and female rats. Physiol. Behav. 130, 99 (2014).
Snigdha, S. et al. Phencyclidine (PCP)-induced disruption in cognitive performance is gender-specific and associated with a reduction in brain-derived neurotrophic factor (BDNF) in specific regions of the female rat brain. J. Mol. Neurosci https://doi.org/10.1007/s12031-010-9447-5 (2010).
Puskarjov, M. et al. BDNF is required for seizure-induced but not developmental up-regulation of KCC2 in the neonatal hippocampus. Neuropharmacology 88, 103–109 (2015).
Kwakowsky, A., Herbison, A. E. & Ábrahám, I. M. The role of cAMP response element-binding protein in estrogen negative feedback control of gonadotropin-releasing hormone neurons. J. Neurosci. 32, 11309–11317 (2012).
Kwakowsky, A., Cheong, R. Y., Herbison, A. E. & Ábrahám, I. M. Non-classical effects of estradiol on cAMP responsive element binding protein phosphorylation in gonadotropin-releasing hormone neurons: Mechanisms and role. Front. Neuroendocrinol. 35, 31–41 (2014).
Malyala, A., Kelly, M. J. & Rønnekleiv, O. K. Estrogen modulation of hypothalamic neurons: Activation of multiple signaling pathways and gene expression changes. Steroids 70, 397–406 (2005).
Im, A. & Ae, H. Major sex differences in non-genomic estrogen actions on intracellular signaling in mouse brain in vivo. Neuroscience 131, 945–951 (2005).
Vasudevan, N. & Pfaff, D. W. Non-genomic actions of estrogens and their interaction with genomic actions in the brain. Front. Neuroendocrinol. 29, 238–257 (2008).
Romano, N., Lee, K., Abraham, I. M., Jasoni, C. L. & Herbison, A. E. Nonclassical estrogen modulation of presynaptic GABA terminals modulates calcium dynamics in gonadotropin-releasing hormone neurons. Endocrinol. 149, 5335–5344 (2008).
Calvo-Flores Guzmán, B. et al. The GABAergic system as a therapeutic target for Alzheimer’s disease. J. Neurochem. 146, 649–669 (2018).
Smith, S. S. Withdrawal properties of a neuroactive steroid: Implications for GABA(A) receptor gene regulation in the brain and anxiety behavior. Steroids 67, 519–528 (2002).
Velíšková, J. & DeSantis, K. A. Sex and hormonal influences on seizures and epilepsy. Horm. Behav. 63, 267–277 (2013).
McHugh, J. C. & Delanty, N. Epidemiology and classification of epilepsy: Gender comparisons. Int. Rev. Neurobiol. 83, 11–26 (2008).
Fernandez, R. et al. A molecular method for classifying the genotypes obtained in a breeding colony from testicular feminized (Tfm) rats. Horm. Metab. Res. 35, 197–200 (2003).
Pallarés, M. E. et al. Prenatal maternal restraint stress exposure alters the reproductive hormone profile and testis development of the rat male offspring. Stress 16, 429–440 (2013).
Ouardouz, M., Lema, P., Awad, P. N., Di Cristo, G. & Carmant, L. N-methyl-d-aspartate, hyperpolarization-activated cation current (I h) and -aminobutyric acid conductances govern the risk of epileptogenesis following febrile seizures in rat hippocampus. Eur. J. Neurosci. 31, 1252–1260 (2010).
Sanon, N. T., Pelletier, J. G., Carmant, L. & Lacaille, J. C. Interneuron subtype specific activation of mGluR15 during epileptiform activity in hippocampus. Epilepsia 51, 1607–1618 (2010).
Acknowledgements
The authors thank Dr. Lionel Carmant (LC) for initiating the project and his mentorship, and Dr. Cindy Jordan for kindly providing the TFM female rat carriers. This work was supported by a grant from the NSERC (RGPIN-2015-05333, LC). DCW was supported by Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq), Fonds de recherche du Québec—Santé (FRQS) and Foundation of Stars/Foundation des étoiles, Montréal (Quebec) Canada.
Author information
Authors and Affiliations
Contributions
D.C.W. and N.T.S. designed the study. D.C.W., T.S., A.R.E., A.S.F.N. performed experiments. D.C.W., J.S.C. and A.O.S.C. analysed data. D.C.W., G.D.C., A.G.W. wrote the manuscript. All authors reviewed the manuscript.
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Wolf, D.C., Sanon, N.T., Cunha, A.O.S. et al. Sex-specific differences in KCC2 localisation and inhibitory synaptic transmission in the rat hippocampus. Sci Rep 12, 3186 (2022). https://doi.org/10.1038/s41598-022-06769-5
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41598-022-06769-5
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.